Heidi Overton chosen to lead US FDA; Trump highlights her health leadership

President Donald Trump announced on Wednesday that Dr. Heidi Overton has been selected to lead the Food and Drug Administration (FDA). Overton, a physician and deputy director of the White House National Policy Council, has been a key advisor on health initiatives during Trump's second term and is considered a trusted figure within his administration.

Overton has actively championed Trump's health agenda, focusing on objectives such as accelerating cures, fostering innovation, reducing drug prices, and promoting the "Make America Healthy Again" movement. Trump described her as an intelligent and respected "star" who would advance these priorities.

However, Overton's potential tenure at the FDA will involve navigating complex and often conflicting priorities. She will need to balance Trump's specific demands with the traditional Republican anti-regulatory stance and the Health Secretary's anti-corporate positions. These challenges echo those faced by the previous FDA chief, Dr. Marty Makary, who resigned in May, leaving unfinished projects related to ultra-processed foods, antidepressants, and COVID-19 vaccines.

Overton's background includes medical studies at the University of New Mexico and a clinical research doctorate from Johns Hopkins University. Before joining the Trump administration, she was a policy director at the conservative America First Policy Institute. She has appeared with Trump at events promoting initiatives like drug price agreements and a controversial order to separate the MMR vaccine into three distinct immunizations, despite medical consensus. Overton has also expressed criticism of abortion pills, positioning her to potentially reverse FDA regulations that have increased their accessibility.